Pharmaron Beijing Co., Ltd. — Investor Relations & Filings
Pharmaron Beijing Co., Ltd. is a premier R&D service provider for the life sciences industry, offering a comprehensive, fully integrated platform for drug discovery, development, and manufacturing. The company supports global pharmaceutical and biotechnology partners through a wide range of services, including laboratory chemistry, biology, DMPK, pharmacology, and safety assessment. Its capabilities extend to clinical development services and commercial-scale manufacturing for small molecules, biologics, and cell and gene therapies. By leveraging advanced technology and a global network of facilities, the company facilitates the transition of drug candidates from initial concept to market approval, optimizing the efficiency and success of the drug development lifecycle.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 《董事、高级管理人员薪酬管理制度》（2026年3月） | 2026-03-30 | Chinese | |
| 关于“质量回报双提升”行动方案的进展公告 | 2026-03-30 | Chinese | |
| 关于使用部分自有资金购买理财产品的公告 | 2026-03-30 | Chinese | |
| 2025年年度报告摘要 | 2026-03-30 | Chinese | |
| 2025年度独立非执行董事述职报告（曾坤鸿） | 2026-03-30 | Chinese | |
| 2025年度独立非执行董事述职报告（曾劲峰） | 2026-03-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38902317 | 《董事、高级管理人员薪酬管理制度》（2026年3月） | 2026-03-30 | Chinese | ||
| 38902312 | 关于“质量回报双提升”行动方案的进展公告 | 2026-03-30 | Chinese | ||
| 38902309 | 关于使用部分自有资金购买理财产品的公告 | 2026-03-30 | Chinese | ||
| 38902306 | 2025年年度报告摘要 | 2026-03-30 | Chinese | ||
| 38902303 | 2025年度独立非执行董事述职报告（曾坤鸿） | 2026-03-30 | Chinese | ||
| 38902301 | 2025年度独立非执行董事述职报告（曾劲峰） | 2026-03-30 | Chinese | ||
| 38902298 | 关于增加注册资本、修订《公司章程》的公告 | 2026-03-30 | Chinese | ||
| 38902288 | 关于2026年度对外担保额度预计的公告 | 2026-03-30 | Chinese | ||
| 38902285 | 董事会关于公司2025年度套期保值产品交易的专项说明 | 2026-03-30 | Chinese | ||
| 38902281 | 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-03-30 | Chinese | ||
| 38902279 | 2025年年度审计报告 | 2026-03-30 | Chinese | ||
| 38902278 | 2025年年度报告 | 2026-03-30 | Chinese | ||
| 38902275 | 关于拟续聘2026年度境内财务及内控审计机构的公告 | 2026-03-30 | Chinese | ||
| 38902266 | 2025年度独立非执行董事述职报告（余坚） | 2026-03-30 | Chinese | ||
| 38902250 | 2025年环境、社会及管治报告 | 2026-03-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Pharmaron Beijing Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55731/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55731 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55731 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55731 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55731}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pharmaron Beijing Co., Ltd. (id: 55731)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.